ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO012

Case-Based Online Education Significantly Improved Nephrologists' Knowledge and Confidence in Managing CKD-aP

Session Information

  • Educational Research
    November 03, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Educational Research

  • 900 Educational Research


  • Bell, Elaine, Medscape Education Global, London, NA, United Kingdom
  • Marko, Joy, Medscape LLC, New York, New York, United States
  • Burton, James, Dept of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom

Chronic kidney disease-associated pruritus (CKD-aP) is a common and distressing condition that affects ≥60% of people undergoing haemodialysis, with 20-40% reporting moderate-to-severe pruritus. Intense itching can lead to poor sleep quality, depression, reduced quality of life, increased risk of infection, and an increased risk of death. However, there are limited options for controlling CKD-aP, making it a challenging condition to manage effectively.


Nephrologists participated in an online case-based activity entitled ‘Patient Case Challenges in CKD-aP’ (launched 17 May 2021, data collection by 17 Sept. 2021). Educational effect was assessed using a repeated-pair design, pre-/post-assessment. A paired samples t-test was conducted for significance testing on overall average number of correct responses and for confidence rating. Cohen’s d estimated the effect size of the education on number of correct responses (<.20 modest, .20-.49 small, .59-.79 moderate, ≥.80 large). A series of McNemar’s tests were conducted at the question level (5% significance level, P <.05).


Nephrologists (n=107) significantly improved their knowledge regarding diagnosis & severity assessment of CKD-aP (55% correct answer at baseline, 97% post-assessment), novel therapies for CKD-aP (59% correct answer at baseline, 95% post-assessment), and optimizing outcomes for people with CKD-aP (60% correct answer at baseline, 97% post-assessment) (all P <.001)
64% of nephrologists reported improved confidence in understanding treatment options for CKD-aP
98% of nephrologists reported that the education would improve their performance, leading to better patient outcomes


These results highlight the benefits of case-based education in helping nephrologists understand how to better manage CKD-aP. Further education would be beneficial to support nephrologists to translate knowledge of novel treatment strategies into clinical practice in order to optimize outcomes.


  • Commercial Support –